CIC biomaGUNE Revenue and Competitors
Estimated Revenue & Valuation
- CIC biomaGUNE's estimated annual revenue is currently $19.5M per year.
- CIC biomaGUNE's estimated revenue per employee is $112,200
Employee Data
- CIC biomaGUNE has 174 Employees.
- CIC biomaGUNE grew their employee count by 14% last year.
CIC biomaGUNE's People
| Name | Title | Email/Phone |
|---|
CIC biomaGUNE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $45.4M | 356 | 11% | N/A | N/A |
#2 | $21.7M | 193 | 20% | N/A | N/A |
#3 | $13.3M | 130 | 30% | N/A | N/A |
#4 | $25.8M | 230 | 33% | N/A | N/A |
#5 | $13M | 127 | 11% | N/A | N/A |
#6 | $14M | 137 | 18% | N/A | N/A |
#7 | $19.5M | 174 | 14% | N/A | N/A |
#8 | $5.1M | 56 | N/A | N/A | N/A |
#9 | $15.8M | 141 | N/A | N/A | N/A |
#10 | $16.6M | 148 | 5% | N/A | N/A |
What Is CIC biomaGUNE?
CIC biomaGUNE is a non-profit research organization created to promote scientific research and technological innovation at the highest levels in the Basque Country following the BIOBASQUE policy in order to create a new business sector based on biosciences.
keywords:N/A
N/A
Total Funding
174
Number of Employees
$19.5M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CIC biomaGUNE News
La profesora Ikerbasque y directora científica de CIC biomaGUNE Aitziber López Cortajarena ha sido reconocida con el Premio a la Excelencia...
... organizado por el CIC Biomagune, centro en el que investiga el químico orgánico Maurizio Prato, uno de los anfitriones del evento y uno...
CIC biomaGUNE BDIH-ren bitartez euskal enpresei irudi molekularrei, medikuntza birsortzaileari eta biomaterialei aplikatutako nanoegiturak...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $39.2M | 174 | -10% | N/A |
#2 | $19.1M | 174 | 19% | N/A |
#3 | $34.5M | 174 | 7% | N/A |
#4 | $46.9M | 174 | 15% | N/A |
#5 | $15M | 174 | 12% | N/A |